尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Paul Sandland. Insider active across 1 company, notably Dechra Pharmaceuticals PLC. In total, 7 disclosures have been logged. Activity tracked since 15 January 2024. The latest transaction was disclosed on 15 January 2024 (Purchase). Regulator: RNS (LSE). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Paul Sandland is a declarant connected to Dechra Pharmaceuticals PLC, where he is Director/PDMR. He has 7 filings in total, and across the 7 sampled recent filings these were purchases totaling EUR 29372, with no sales, between 2023-10-18 and 2024-01-15.